The Biomarker Challenge
Biomarkers’ discovery is an area becoming increasingly important in research and industry, giving rise to new areas of diagnostic and treatment, and could form the foundation for new innovative drivers for both researchers, enterprises and SMEs.
According to “Biomarkers Market - Global Forecast to 2020” the global biomarkers market expects to reach a market share of $45.55 Billion by 2020 of which healthcare and R&D expenditure are the key growth drivers.
Nonetheless, the challenges for market uptake of these innovations are significant, as the development and commercialization of biomarkers is time consuming, difficult and expensive.
Another challenge is to involve industry (pharmaceutical and diagnostic enterprises, SMEs, investors) much earlier in the development and commercialization process of biomarkers, while research institutions need guidance to select the most relevant biomarker discoveries and conduct a development plan that meets early requirements from relevant industry partner.
By enabling better and more efficient commercialization of biomarkers, the overall output of the BIC project will contribute in improving realization and competetiveness of biomarker discovery with the Baltic Sea Region.
Therefore, BIC offers various tools:
The project’s budget is EUR 2.55 million and is co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme with EUR 1.96 million.
A community to share the outputs and insights of the EU Interreg Baltic Sea Region Project "BIC - Biomarker Commercialization"
Read more about the project: www.biomarker.nuRead more